Management of Pulmonary Metastasis.
- Author:
Hun Mo RYOO
1
Author Information
1. Division of Hemato-oncology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea. rhmrhm@cu.ac.kr
- Publication Type:Review
- Keywords:
Pulmonary metastasis;
Metastasectomy;
SBRT;
RFA
- MeSH:
Life Expectancy;
Lung;
Metastasectomy;
Neoplasm Metastasis;
Patient Selection
- From:Korean Journal of Medicine
2011;81(3):289-299
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The lung is a common site for metastasis of malignant tumors from other organs. The metastatic cascade is a complex process that involves a series of events. Tumors can spread to the lung through hematogenous or lymphangitic routes. In the absence of extrathoracic metastasis, complete resection is associated with increased survival, regardless of histology. With appropriate patient selection, life expectancy is often improved with pulmonary metastasectomy. Stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA) are 2 approaches that have been increasingly reported for pulmonary tumors. Although these new therapies have yet to match the long-term success rates of surgical therapy, the techniques demonstrate good results in treating high-risk surgical candidates with metastatic lesions to the lungs that would otherwise be considered with resection. This review will focus on the role of local therapy in oligometastasis that arise in the lung.
